Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities

Hamid Chalian, James K. O’Donnell, Michael Bolen, Prabhakar Rajiah

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Abstract: The cardiovascular system is affected by a wide range of pathological processes, including neoplastic, inflammatory, ischemic, and congenital aetiology. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are state-of-the-art imaging modalities used in the evaluation of these cardiovascular disorders. MRI has good spatial and temporal resolutions, tissue characterization and multi-planar imaging/reconstruction capabilities, which makes it useful in the evaluation of cardiac morphology, ventricular and valvar function, disease characterization, and evaluation of myocardial viability. FDG-PET provides valuable information on the metabolic activity of the cardiovascular diseases, including ischemia, inflammation, and neoplasm. MRI and FDG-PET can provide complementary information on the evaluation of several cardiovascular disorders. For example, in cardiac masses, FDG-PET provides the metabolic information for indeterminate cardiac masses. MRI can be used for localizing and characterizing abnormal hypermetabolic foci identified incidentally on PET scan and also for local staging. A recent advance in imaging technology has been the development of integrated PET/MRI systems that utilize the advantages of PET and MRI in a single examination. The goal of this manuscript is to provide a comprehensive review on the incremental value of PET and MRI in the evaluation of cardiovascular diseases. Main Messages: • MRI has good spatial and temporal resolutions, tissue characterization, and multi-planar reconstruction • FDG-PET provides valuable information on the metabolic activity of cardiovascular disorders • PET and MRI provide complementary information on the evaluation of cardiovascular disorders

Original languageEnglish (US)
Pages (from-to)485-503
Number of pages19
JournalInsights into Imaging
Volume7
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Cardiovascular Abnormalities
Positron-Emission Tomography
Magnetic Resonance Imaging
Cardiovascular Diseases
Ventricular Function
Pathologic Processes
Cardiovascular System
Ischemia

Keywords

  • Cardiac
  • Ischemia
  • MRI
  • Neoplasm
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities. / Chalian, Hamid; O’Donnell, James K.; Bolen, Michael; Rajiah, Prabhakar.

In: Insights into Imaging, Vol. 7, No. 4, 01.08.2016, p. 485-503.

Research output: Contribution to journalReview article

Chalian, Hamid ; O’Donnell, James K. ; Bolen, Michael ; Rajiah, Prabhakar. / Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities. In: Insights into Imaging. 2016 ; Vol. 7, No. 4. pp. 485-503.
@article{0e11cc114e7b49ea943499c3195afcdf,
title = "Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities",
abstract = "Abstract: The cardiovascular system is affected by a wide range of pathological processes, including neoplastic, inflammatory, ischemic, and congenital aetiology. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are state-of-the-art imaging modalities used in the evaluation of these cardiovascular disorders. MRI has good spatial and temporal resolutions, tissue characterization and multi-planar imaging/reconstruction capabilities, which makes it useful in the evaluation of cardiac morphology, ventricular and valvar function, disease characterization, and evaluation of myocardial viability. FDG-PET provides valuable information on the metabolic activity of the cardiovascular diseases, including ischemia, inflammation, and neoplasm. MRI and FDG-PET can provide complementary information on the evaluation of several cardiovascular disorders. For example, in cardiac masses, FDG-PET provides the metabolic information for indeterminate cardiac masses. MRI can be used for localizing and characterizing abnormal hypermetabolic foci identified incidentally on PET scan and also for local staging. A recent advance in imaging technology has been the development of integrated PET/MRI systems that utilize the advantages of PET and MRI in a single examination. The goal of this manuscript is to provide a comprehensive review on the incremental value of PET and MRI in the evaluation of cardiovascular diseases. Main Messages: • MRI has good spatial and temporal resolutions, tissue characterization, and multi-planar reconstruction • FDG-PET provides valuable information on the metabolic activity of cardiovascular disorders • PET and MRI provide complementary information on the evaluation of cardiovascular disorders",
keywords = "Cardiac, Ischemia, MRI, Neoplasm, PET",
author = "Hamid Chalian and O’Donnell, {James K.} and Michael Bolen and Prabhakar Rajiah",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s13244-016-0494-5",
language = "English (US)",
volume = "7",
pages = "485--503",
journal = "Insights into Imaging",
issn = "1869-4101",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "4",

}

TY - JOUR

T1 - Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities

AU - Chalian, Hamid

AU - O’Donnell, James K.

AU - Bolen, Michael

AU - Rajiah, Prabhakar

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Abstract: The cardiovascular system is affected by a wide range of pathological processes, including neoplastic, inflammatory, ischemic, and congenital aetiology. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are state-of-the-art imaging modalities used in the evaluation of these cardiovascular disorders. MRI has good spatial and temporal resolutions, tissue characterization and multi-planar imaging/reconstruction capabilities, which makes it useful in the evaluation of cardiac morphology, ventricular and valvar function, disease characterization, and evaluation of myocardial viability. FDG-PET provides valuable information on the metabolic activity of the cardiovascular diseases, including ischemia, inflammation, and neoplasm. MRI and FDG-PET can provide complementary information on the evaluation of several cardiovascular disorders. For example, in cardiac masses, FDG-PET provides the metabolic information for indeterminate cardiac masses. MRI can be used for localizing and characterizing abnormal hypermetabolic foci identified incidentally on PET scan and also for local staging. A recent advance in imaging technology has been the development of integrated PET/MRI systems that utilize the advantages of PET and MRI in a single examination. The goal of this manuscript is to provide a comprehensive review on the incremental value of PET and MRI in the evaluation of cardiovascular diseases. Main Messages: • MRI has good spatial and temporal resolutions, tissue characterization, and multi-planar reconstruction • FDG-PET provides valuable information on the metabolic activity of cardiovascular disorders • PET and MRI provide complementary information on the evaluation of cardiovascular disorders

AB - Abstract: The cardiovascular system is affected by a wide range of pathological processes, including neoplastic, inflammatory, ischemic, and congenital aetiology. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are state-of-the-art imaging modalities used in the evaluation of these cardiovascular disorders. MRI has good spatial and temporal resolutions, tissue characterization and multi-planar imaging/reconstruction capabilities, which makes it useful in the evaluation of cardiac morphology, ventricular and valvar function, disease characterization, and evaluation of myocardial viability. FDG-PET provides valuable information on the metabolic activity of the cardiovascular diseases, including ischemia, inflammation, and neoplasm. MRI and FDG-PET can provide complementary information on the evaluation of several cardiovascular disorders. For example, in cardiac masses, FDG-PET provides the metabolic information for indeterminate cardiac masses. MRI can be used for localizing and characterizing abnormal hypermetabolic foci identified incidentally on PET scan and also for local staging. A recent advance in imaging technology has been the development of integrated PET/MRI systems that utilize the advantages of PET and MRI in a single examination. The goal of this manuscript is to provide a comprehensive review on the incremental value of PET and MRI in the evaluation of cardiovascular diseases. Main Messages: • MRI has good spatial and temporal resolutions, tissue characterization, and multi-planar reconstruction • FDG-PET provides valuable information on the metabolic activity of cardiovascular disorders • PET and MRI provide complementary information on the evaluation of cardiovascular disorders

KW - Cardiac

KW - Ischemia

KW - MRI

KW - Neoplasm

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84979085249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979085249&partnerID=8YFLogxK

U2 - 10.1007/s13244-016-0494-5

DO - 10.1007/s13244-016-0494-5

M3 - Review article

VL - 7

SP - 485

EP - 503

JO - Insights into Imaging

JF - Insights into Imaging

SN - 1869-4101

IS - 4

ER -